{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T12:46:29Z","timestamp":1785933989787,"version":"3.56.0"},"reference-count":67,"publisher":"BMJ","issue":"3","license":[{"start":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T00:00:00Z","timestamp":1785888000000},"content-version":"unspecified","delay-in-days":65,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100016309","name":"Bayer, United Kingdom","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016309","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open Ophth"],"accepted":{"date-parts":[[2026,7,14]]},"published-print":{"date-parts":[[2026,6]]},"abstract":"<jats:p>Macular disease is the leading cause of vision loss in the United Kingdom, affecting nearly 1.5\u2009million people. Vascular endothelial growth factor (VEGF) has a major role in the onset and progression of vision-threatening macular conditions such as neovascular age-related macular degeneration, diabetic macular oedema and retinal vein occlusion. Anti-VEGF treatments, given by intravitreal injection, can prevent vision loss and may improve vision but must be started quickly before sight loss is irreversible. Informed by an observational study using Hospital Episode Statistics and the Emergency Care Data Set in England and a Costed Integrated Patient Scenario, we identify issues within the current pathway in England. Our key recommendations to optimise care and improve patient outcomes include: (1) increasing public awareness of macular disease to reduce late presentation; (2) ensuring the right patients are seen in the right place at the right time by improving quality and priority of optometrist referrals and by specialists directing patients with conditions such as diabetes and hypertension to community optometrists in the first instance; (3) planning for current and future demand and capacity using innovative solutions to manage expected increases in medical retina conditions and (4) ensuring patient-centred care. Our evidence should encourage National Health Service organisations at all levels to review macular disease pathways to address immediate issues and plan for the future. A shift in care delivery is needed, embracing scalable sustainable solutions, earlier diagnosis and treatment, improved access to more durable therapies, wider adoption of digital technologies and care closer to home.<\/jats:p>","DOI":"10.1136\/bmjophth-2025-002663","type":"journal-article","created":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T11:50:11Z","timestamp":1785930611000},"page":"e002663","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Optimising the patient pathway for macular conditions requiring intravitreal injections"],"prefix":"10.1136","volume":"11","author":[{"given":"Elizabeth","family":"Wilkinson","sequence":"first","affiliation":[{"name":"Royal Devon University Healthcare NHS Foundation Trust, Exeter, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sasha","family":"Beresford","sequence":"additional","affiliation":[{"name":"NHS Bristol, North Somerset and South Gloucestershire ICB, Bristol, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bushra","family":"Mushtaq","sequence":"additional","affiliation":[{"name":"Birmingham and Midland Eye Centre, Birmingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serena","family":"Salvatore","sequence":"additional","affiliation":[{"name":"University Hospitals Bristol and Weston NHS Foundation Trust, Bristol, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sobha","family":"Sivaprasad","sequence":"additional","affiliation":[{"name":"Moorfields Eye Hospital NHS Foundation Trust, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-9674-6027","authenticated-orcid":false,"given":"Kieran","family":"Brown","sequence":"additional","affiliation":[{"name":"HSJ Information, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1980-3877","authenticated-orcid":false,"given":"Jemma S","family":"Carter","sequence":"additional","affiliation":[{"name":"Independent Medical Writer, Peterborough, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jyotika","family":"Singh","sequence":"additional","affiliation":[{"name":"HSJ Information, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy","family":"Schrire","sequence":"additional","affiliation":[{"name":"Bayer Pharmaceuticals, Reading, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3445-7960","authenticated-orcid":false,"given":"Thomas John Godwin","family":"Chase","sequence":"additional","affiliation":[{"name":"Bayer Pharmaceuticals, Reading, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,8,5]]},"reference":[{"key":"2026080504500493000_11.3.e002663.1","unstructured":"Macular Society, Fight for Sight\/Vision Foundation, RNIB, Association of Optometrists, Royal College of Optometrists, Roche . Laying the foundations for the future of eye health in England. 2023. Available: https:\/\/eyeshaveit.co.uk\/wp-content\/uploads\/2024\/06\/Laying-the-foundations-for-the-future-of-eye-health-in-England.pdf [Accessed Sep 2025]."},{"key":"2026080504500493000_11.3.e002663.2","unstructured":"Association of Optometrists (AOP) . RNIB predicts 27% rise in people living with sight loss in the UK by 2035. Available: https:\/\/www.aop.org.uk\/ot\/news\/2024\/10\/14\/rnib-predicts-27-rise-in-people-living-with-sight-loss-in-the-uk-by-2035 [Accessed Sep 2025]."},{"key":"2026080504500493000_11.3.e002663.3","unstructured":"RNIB . World sight day 2024. Available: https:\/\/www.rnib.org.uk\/news\/world-sight-day-2024\/ [Accessed Sep 2025]."},{"key":"2026080504500493000_11.3.e002663.4","unstructured":"World Health Organization . Blindness and visual impairment. Available: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/blindness-and-visual-impairment [Accessed Sep 2025]."},{"key":"2026080504500493000_11.3.e002663.5","unstructured":"Macular Society . What is macular disease. Available: https:\/\/www.macularsociety.org\/macular-disease\/ [Accessed Sep 2025]."},{"key":"2026080504500493000_11.3.e002663.6","unstructured":"National Institute for Health and Care Excellence (NICE) . Clinical knowledge summary: macular degeneration \u2013 age related. 2022. Available: https:\/\/cks.nice.org.uk\/topics\/macular-degeneration-age-related [Accessed Sep 2025]."},{"key":"2026080504500493000_11.3.e002663.7","unstructured":"Hobbs SD , Tripathy K , Pierce K . Wet age-related macular degeneration (AMD). Available: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK572147\/ [accessed Sep 2025]"},{"key":"2026080504500493000_11.3.e002663.8","unstructured":"Kohli P , Tripathy K , Patel BC . Macular edema. Available: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK576396\/ [Accessed Sep 2025]."},{"key":"2026080504500493000_11.3.e002663.9","unstructured":"Blair K , Czyz CN . Central retinal vein occlusion. Available: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK525985\/ [Accessed Sep 2025]."},{"key":"2026080504500493000_11.3.e002663.10","unstructured":"Shukla UV , Tripathy K . Diabetic retinopathy. 2025. Available: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK560805\/ [Accessed Sep 2025]."},{"key":"2026080504500493000_11.3.e002663.11","unstructured":"RNIB . Fact sheet: anti-VEGF treatment. Available: https:\/\/www.rnib.org.uk\/documents\/686\/Anti_VEGF_2024.docx [Accessed Sep 2025]."},{"key":"2026080504500493000_11.3.e002663.12","first-page":"12","article-title":"Second-generation anti-VEGF agents for neovascular AMD","volume":"22","author":"Walter","year":"2025","journal-title":"Retin Phys"},{"key":"2026080504500493000_11.3.e002663.13","unstructured":"NICE . Serious eye disorders. Quality standard 180. Available: https:\/\/www.nice.org.uk\/guidance\/qs180\/resources\/serious-eye-disorders-pdf-75545714654917 [Accessed Sep 2025]."},{"key":"2026080504500493000_11.3.e002663.14","unstructured":"National Ophthalmology Database Audit . The third report of age-related macular degeneration audit (AMD). Patients starting treatment for neovascular AMD in the 2022 NHS year (01 April 2022 to 31 March 2023). 2025. Available: https:\/\/live-nod-audit.pantheonsite.io\/sites\/default\/files\/2025-03\/NOD%20Audit%20Full%20Annual%20Report%202025_Final%20%281%29.pdf [Accessed May 2025]."},{"key":"2026080504500493000_11.3.e002663.15","unstructured":"Royal College of Ophthalmologists (RCO) . Commissioning guidance: age related macular degeneration services: recommendations. 2024. Available: https:\/\/www.rcophth.ac.uk\/resources-listing\/commissioning-guidance-age-related-macular-degeneration-services\/ [Accessed Sep 2025]."},{"key":"2026080504500493000_11.3.e002663.16","unstructured":"RCO . Clinical guidelines: retinal vein occlusion (RVO). 2022. Available: https:\/\/www.rcophth.ac.uk\/wp-content\/uploads\/2015\/07\/Retinal-Vein-Occlusion-Guidelines-2022.pdf [Accessed Sep 2025]."},{"key":"2026080504500493000_11.3.e002663.17","unstructured":"NHS England . NHS diabetic eye screening pathway standards from 1st October 2024. 2024. Available: https:\/\/www.gov.uk\/government\/publications\/diabetic-eye-screening-programme-standards\/nhs-diabetic-eye-screening-pathway-standards-from-1st-october-2024-public-facing-guidance-information [Accessed Sep 2025]."},{"key":"2026080504500493000_11.3.e002663.18","unstructured":"NHS England . Referral to treatment. Available: https:\/\/www.england.nhs.uk\/rtt\/ [Accessed Sep 2025]."},{"key":"2026080504500493000_11.3.e002663.19","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2007.03.008"},{"key":"2026080504500493000_11.3.e002663.20","unstructured":"Regillo CD . Second-generation anti-VEGFs in age-related macular degeneration. Available: https:\/\/glaucomatoday.com\/articles\/2025-mar-apr-insert\/second-generation-anti-vegfs-in-age-related-macular-degeneration [Accessed Sep 2025]."},{"key":"2026080504500493000_11.3.e002663.21","unstructured":"Getting It Right First Time (GIRFT) . Ophthalmology: girft programme national specialty report. 2019. Available: https:\/\/gettingitrightfirsttime.co.uk\/wp-content\/uploads\/2019\/12\/OphthalmologyReportGIRFT19P-FINAL.pdf [Accessed Sep 2025]."},{"key":"2026080504500493000_11.3.e002663.22","unstructured":"Centre for Ageing Better . Our ageing population: the state of ageing 2025. Available: https:\/\/ageing-better.org.uk\/our-ageing-population-state-ageing-2025 [Accessed Sep 2025]."},{"key":"2026080504500493000_11.3.e002663.23","unstructured":"Office for Health Improvement and Disparities . Diabetes profile: statistical commentary. 2025. Available: https:\/\/www.gov.uk\/government\/statistics\/diabetes-profile-update-march-2025\/diabetes-profile-statistical-commentary-march-2025 [Accessed Sep 2025]."},{"key":"2026080504500493000_11.3.e002663.24","unstructured":"AOP . NHS patient backlogs are leading to life-changing sight loss. Available: https:\/\/www.aop.org.uk\/our-voice\/media-centre\/press-releases\/2023\/03\/21\/nhs-patient-backlogs-are-leading-to-life-changing-sight-loss [Accessed Apr 2025]."},{"key":"2026080504500493000_11.3.e002663.25","unstructured":"NHS England . Hospital episode statistics (HES). Available: https:\/\/digital.nhs.uk\/data-and-information\/data-tools-and-services\/data-services\/hospital-episode-statistics [Accessed Sep 2025]."},{"key":"2026080504500493000_11.3.e002663.26","unstructured":"NHS England . Emergency care data set (ECDs). Available: https:\/\/digital.nhs.uk\/data-and-information\/data-collections-and-data-sets\/data-sets\/emergency-care-data-set-ecds [Accessed Sep 2025]."},{"key":"2026080504500493000_11.3.e002663.27","unstructured":"HSJ Advisory . Ophthalmology care in England: looking to the future. 2025. Available: https:\/\/pro.bayer.co.uk\/sites\/g\/files\/rptbxg291\/files\/2025-10\/Ophthalmology_SOTN_Report.pdf [Accessed Oct 2025]."},{"key":"2026080504500493000_11.3.e002663.28","unstructured":"HSJ Advisory . Managing wet AMD: aiming to optimise the patient journey: Jane\u2019s journey \u2013 a hypothetical costed integrated patient scenario. 2025. Available: https:\/\/pro.bayer.co.uk\/sites\/g\/files\/rptbxg291\/files\/2025-07\/Cost_Integrated_Patient_Scenario_Report.pdf [Accessed Sep 2025]."},{"key":"2026080504500493000_11.3.e002663.29","doi-asserted-by":"publisher","DOI":"10.1111\/j.1475-1313.2010.00797.x"},{"key":"2026080504500493000_11.3.e002663.30","unstructured":"NICE . Age-related macular degeneration. NICE guidance 82. 2018. Available: https:\/\/www.nice.org.uk\/guidance\/ng82 [Accessed Sep 2025]."},{"key":"2026080504500493000_11.3.e002663.31","unstructured":"College of Optometrists . Annex 4: urgency of referrals table. Available: https:\/\/www.college-optometrists.org\/clinical-guidance\/guidance\/guidance-annexes\/annex-4-urgency-of-referrals-table [Accessed Sep 2025]."},{"key":"2026080504500493000_11.3.e002663.32","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1111\/opo.13183","article-title":"Assessment of optometrists\u2019 referral accuracy and contributing factors: A review","volume":"43","author":"Carmichael","year":"2023","journal-title":"Ophthalmic Physiologic Optic"},{"key":"2026080504500493000_11.3.e002663.33","doi-asserted-by":"publisher","DOI":"10.1258\/shorts.2010.010079"},{"key":"2026080504500493000_11.3.e002663.34","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1111\/opo.13455","article-title":"The quality, accuracy and appropriateness of UK optometric age\u2010related macular degeneration referrals","volume":"45","author":"Fulcher","year":"2025","journal-title":"Ophthalmic Physiologic Optic"},{"key":"2026080504500493000_11.3.e002663.35","doi-asserted-by":"crossref","first-page":"293","DOI":"10.2147\/OPTO.S470577","article-title":"A novel optometry-led decision-making community referral refinement scheme for neovascular age-related macular degeneration screening","volume":"16","author":"Sanders","year":"2024","journal-title":"Clin Optom"},{"key":"2026080504500493000_11.3.e002663.36","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.g2084","article-title":"NHS sight tests include unevaluated screening examinations that lead to waste","volume":"348","author":"Clarke","year":"2014","journal-title":"BMJ"},{"key":"2026080504500493000_11.3.e002663.37","unstructured":"General Optical Council . Standards of practice for optometrists and dispensing opticians. Available: https:\/\/optical.org\/standards-and-guidance\/standards\/standards-of-practice-for-optometrists-and-dispens.html [Accessed Sep 2025]."},{"key":"2026080504500493000_11.3.e002663.38","unstructured":"College of Optometrists . Communication, partnership and teamwork: working with colleagues \u2013 referrals. Available: https:\/\/www.college-optometrists.org\/clinical-guidance\/guidance\/communication,-partnership-and-teamwork\/working-with-colleagues\/referrals [Accessed Sep 2025]."},{"key":"2026080504500493000_11.3.e002663.39","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2020-047246","article-title":"Review of referrals reveal the impact of referral content on the triage and management of ophthalmology wait lists","volume":"11","author":"Khou","year":"2021","journal-title":"BMJ Open"},{"key":"2026080504500493000_11.3.e002663.40","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1038\/s41433-021-01728-2","article-title":"Referrals from community optometrists to the hospital eye service in Scotland and England","volume":"36","author":"Shah","year":"2022","journal-title":"Eye (Lond)"},{"key":"2026080504500493000_11.3.e002663.41","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1038\/eye.2008.196","article-title":"Impact of direct electronic optometric referral with ocular imaging to a hospital eye service","volume":"23","author":"Cameron","year":"2009","journal-title":"Eye (Lond)"},{"key":"2026080504500493000_11.3.e002663.42","unstructured":"HSJ Solutions . Organisations collaborate for a single point of access for direct community optometrist referrals, managing 17,000 referrals, improving referral accuracy and patient outcomes. Available: https:\/\/solutions.hsj.co.uk\/direct-referral-system-reduces-wait-times-from-11-days-to-2-hours\/7022735.article [Accessed Sep 2025]."},{"key":"2026080504500493000_11.3.e002663.43","doi-asserted-by":"crossref","unstructured":"Rai BB , Morley MG , Zangmo P , et al . Surgical management of vitreoretinal diseases in Bhutan: A 3-year national study. New Front Ophthalmol 2020;6. doi:10.15761\/NFO.1000251","DOI":"10.15761\/NFO.1000251"},{"key":"2026080504500493000_11.3.e002663.44","unstructured":"HSJ Solutions . Trust launches self-assessing eye-test app for its patients, enabling self-diagnosis from home and thereby improving patient experience and safety. Available: https:\/\/solutions.hsj.co.uk\/home-vision-monitor-app-records-14445-self-tests-enabling-early-disease-control\/7021490.article [Accessed Sep 2025]."},{"key":"2026080504500493000_11.3.e002663.45","unstructured":"HSJ Solutions . Trust develops an AI telephone solution that delivers clinical conversations to cataract patients at an unlimited scale, reducing nurse-led phone calls by 66 per cent. Available: https:\/\/solutions.hsj.co.uk\/ais-clinical-conversations-free-up-550-hours-of-ophthalmic-nurse-employed-time\/7022688.article [Accessed Sep 2025]."},{"key":"2026080504500493000_11.3.e002663.46","unstructured":"HSJ Solutions . Trust set-up a one stop service to maintain treatment cycles of patients with age-related macular degeneration, assessing 2961 patients by ensuring tailored treatment. Available: https:\/\/solutions.hsj.co.uk\/treat-and-extend-model-helps-reduce-1700-hospital-visits-and-increase-capacity\/7021064.article [Accessed Sep 2025]."},{"key":"2026080504500493000_11.3.e002663.47","unstructured":"Macular Society . Home-monitoring app boosts patients\u2019 understanding of macular disease. 2024. Available: https:\/\/www.macularsociety.org\/about\/media\/news\/2024\/july\/home-monitoring-app-boosts-patients-understanding-of-macular-disease\/ [Accessed Sep 2025]."},{"key":"2026080504500493000_11.3.e002663.48","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1007\/s40123-021-00360-3","article-title":"Digital Tools for the Self-Assessment of Visual Acuity: A Systematic Review","volume":"10","author":"Claessens","year":"2021","journal-title":"Ophthalmol Ther"},{"key":"2026080504500493000_11.3.e002663.49","unstructured":"UK Government . 10 year health plan for England: fit for the future. 2025. Available: https:\/\/www.gov.uk\/government\/publications\/10-year-health-plan-for-england-fit-for-the-future [Accessed Sep 2025]."},{"key":"2026080504500493000_11.3.e002663.50","doi-asserted-by":"crossref","DOI":"10.1136\/bmjophth-2021-000801","article-title":"Novel web application for self-assessment of distance visual acuity to support remote consultation: a real-world validation study in children","volume":"6","author":"Allen","year":"2021","journal-title":"BMJ Open Ophthalmol"},{"key":"2026080504500493000_11.3.e002663.51","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2013.10.027"},{"key":"2026080504500493000_11.3.e002663.52","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/j.oret.2022.04.016","article-title":"Analysis of the Long-term Visual Outcomes of ForeseeHome Remote Telemonitoring","volume":"6","author":"Mathai","year":"2022","journal-title":"Ophthalmol Retina"},{"key":"2026080504500493000_11.3.e002663.53","doi-asserted-by":"crossref","first-page":"458","DOI":"10.4103\/tjo.TJO-D-24-00014","article-title":"Seeing the future: Ophthalmology gets \u201ceye-tech\u201d savvy with Internet of Medical Thing","volume":"14","author":"Khurana","year":"2024","journal-title":"Taiwan J Ophthalmol"},{"key":"2026080504500493000_11.3.e002663.54","unstructured":"Legge A , Majcher C . Prospects for remote monitoring in eye care. Rev Optometry 2024. Available: https:\/\/www.reviewofoptometry.com\/article\/prospects-for-remote-monitoring-in-eye-care"},{"key":"2026080504500493000_11.3.e002663.55","unstructured":"Kim JE , Singh JP . Adopting remote monitoring and AI: lessons from cardiology. Retina Today; 2024. Available: https:\/\/retinatoday.com\/articles\/2024-apr\/adopting-remote-monitoring-and-ai-lessons-from-cardiology [Accessed Sep 2025]."},{"key":"2026080504500493000_11.3.e002663.56","doi-asserted-by":"crossref","first-page":"1442758","DOI":"10.3389\/fmed.2024.1442758","article-title":"Home-monitoring\/remote optical coherence tomography in teleophthalmology in patients with eye disorders\u2014a systematic review","volume":"11","author":"Dolar-Szczasny","year":"2024","journal-title":"Front Med"},{"key":"2026080504500493000_11.3.e002663.57","doi-asserted-by":"crossref","DOI":"10.1136\/bmjophth-2019-000276","article-title":"Patient-reported reasons for delay in diagnosis of age-related macular degeneration: a national survey","volume":"4","author":"Parfitt","year":"2019","journal-title":"BMJ Open Ophthalmol"},{"key":"2026080504500493000_11.3.e002663.58","doi-asserted-by":"publisher","DOI":"10.3310\/hta22440"},{"key":"2026080504500493000_11.3.e002663.59","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3897\/pharmacia.71.e119594","article-title":"The impact of DME treatment on diabetic patients","volume":"71","author":"Draganova","year":"2024","journal-title":"PHAR"},{"key":"2026080504500493000_11.3.e002663.60","unstructured":"Cochran ML , Mahabadi N , Czyz CN . Branch retinal vein occlusion. 2023. Available: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK535370\/"},{"key":"2026080504500493000_11.3.e002663.61","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2010.03909.x"},{"key":"2026080504500493000_11.3.e002663.62","doi-asserted-by":"crossref","first-page":"809","DOI":"10.2147\/OPTH.S7631","article-title":"Retinal vein occlusion: pathophysiology and treatment options","volume":"4","author":"Karia","year":"2010","journal-title":"Clin Ophthlamol"},{"key":"2026080504500493000_11.3.e002663.63","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2017-017771","article-title":"Investigation of time to first presentation and extrahospital factors in the treatment of neovascular age-related macular degeneration: a retrospective cross-sectional study","volume":"7","author":"Sim","year":"2017","journal-title":"BMJ Open"},{"key":"2026080504500493000_11.3.e002663.64","first-page":"261","article-title":"Risk factors for late presentation of age-related macular degeneration: pilot case control study","volume":"50","author":"Marinescu","year":"2009","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2026080504500493000_11.3.e002663.65","doi-asserted-by":"crossref","first-page":"e443","DOI":"10.1111\/aos.14568","article-title":"Reasons for late diagnosis of neovascular age\u2010related macular degeneration: a mixed\u2010methods study","volume":"99","author":"Wahl","year":"2021","journal-title":"Acta Ophthalmol (Copenh)"},{"key":"2026080504500493000_11.3.e002663.66","doi-asserted-by":"crossref","DOI":"10.1186\/s12886-019-1191-1","article-title":"Low health literacy levels in patients with chronic retinal disease","volume":"19","author":"Jandorf","year":"2019","journal-title":"BMC Ophthalmol"},{"key":"2026080504500493000_11.3.e002663.67","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.survophthal.2023.09.001","article-title":"Barriers to care in neovascular age-related macular degeneration: Current understanding, developments, and future directions","volume":"69","author":"Choi","year":"2024","journal-title":"Surv Ophthalmol"}],"container-title":["BMJ Open Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjophth-2025-002663","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T11:50:21Z","timestamp":1785930621000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjophth.bmj.com\/lookup\/doi\/10.1136\/bmjophth-2025-002663"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":67,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,8,5]]},"published-print":{"date-parts":[[2026,6]]}},"alternative-id":["10.1136\/bmjophth-2025-002663"],"URL":"https:\/\/doi.org\/10.1136\/bmjophth-2025-002663","relation":{},"ISSN":["2397-3269"],"issn-type":[{"value":"2397-3269","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6]]}}}